Skip to content

e-Mobile Tablet for People With Chronic Conditions

Examining the Usability of Computer Tablets to Promote Symptom Self-management and Engagement in Healthy Behaviors in Adults With Chronic Conditions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02833311
Enrollment
46
Registered
2016-07-14
Start date
2013-11-30
Completion date
2016-04-30
Last updated
2023-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia, Multiple Sclerosis, Osteoarthritis, Parkinson's Disease, Sjögren's Syndrome

Keywords

Neuromusculoskeletal condition

Brief summary

Maintaining a healthy diet and engaging in routine physical activity may help decrease severity of symptoms, prevent secondary conditions, and slow functional decline in people with disabling neuromusculoskeletal conditions. However, people with these conditions face many health barriers to engaging in healthy behaviors. With the advent of portable technologies, such as smart phones, tablets and PDAs, there is a need to explore whether these technologies can help people with disabling conditions to stay motivated and overcome barriers to engaging in healthy behaviors.

Detailed description

The overarching goal of this mixed methods, comparative effectiveness randomized controlled pilot study is to evaluate whether goal setting, self-monitoring, and barrier management using a computer tablet can increase physical activity behavior, improve nutritional habits, and promote health-related quality of life in people with disabling neuromusculoskeletal conditions. Our hypothesis is that, in comparison to the standard care contact control group, participants in both the tablet group and the paper and pencil group will yield significant improvements in healthy behaviors,with the tablet group yielding significantly larger increases.

Interventions

BEHAVIORALComputer Tablet Group

A computer tablet application to set goals,self-monitor healthy behaviors, record condition-related symptom impact, and self-manage a problematic symptom.

BEHAVIORALPaper and Pencil Group

Use of paper and pencil diaries and worksheets to set goals, record condition-related symptom impact, and self-monitor behaviors.

BEHAVIORALContact Control Group

Participants are prescribed an exercise program and given information on healthy eating.

Sponsors

Case Western Reserve University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 76 Years
Healthy volunteers
No

Inclusion criteria

* Physician-confirmed diagnosis of a neuro-musculoskeletal condition or disease of the nerves, muscles, and/or bones that results in functional limitations * Physician consent to engage in home exercise/physical activity program * Regularly inactive (i.e., engaging in 90 minutes or less of purposeful physical activity each week) * Scoring ≤17 mental composite and ≤16 physical composite on the Global Health Questionnaire. * Have internet access (i.e., home, library or other WiFi location)

Exclusion criteria

* If the only disabling condition reported is not considered a neuro-musculoskeletal disease * Have hand-motor function impairments that would limit use of the tablet * Often engage in healthy eating habits * Are frequent fallers (i.e., more than 3 falls per month) * Have a diagnoses of chronic obstructive pulmonary disease, serious mental health disorder, chronic heart failure, myocardial infarction, and other unstable/severe cardiovascular conditions, and uncontrolled diabetes mellitus (e.g., admission to the hospital within the past 6 months for uncontrolled diabetes) * Have severe cognitive deficits * Reports consistently tracking and monitoring health behaviors * Unable to effectively use the tablet technology during the pre-intervention usability demonstration

Design outcomes

Primary

MeasureTime frameDescription
Changes From Baseline in Physical ActivityOutcomes were administered immediately before the intervention and again 6-weeks laterPhysical Activity and Disability Survey-Revised was administered to assess physical activity behavior. Scores can range from -2.7493 to 3.3671. Higher scores on the Physical Activity and Disability Survey-Revised indicates increased physical activity levels.

Secondary

MeasureTime frameDescription
Changes From Baseline in Self-Report Physical FunctionOutcomes were administered immediately before the intervention and again 6-weeks laterPatient Reported Outcome Measurement information System (PROMIS) Physical Function (PF) was used to measure self-report physical function. Measures are scored on a T-score metric. High scores indicate more of the concept being measured. A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.
Changes From Baseline in 6-minute Walking TestOutcomes were administered immediately before the intervention and again 6-weeks later
Changes From Baseline in Self-EfficacyOutcomes were administered immediately before the intervention and again 6-weeks laterExercise Confidence Survey was used to measure self-efficacy. The survey asks about confidence in sticking to an exercise program and making time for exercise. This is a 12 item questionnaire and scores ranges from 1 to 60. A higher score indicates increased confidence to engage in exercise.
Changes From Baseline in WeightOutcomes were administered immediately before the intervention and again 6-weeks later

Countries

United States

Participant flow

Participants by arm

ArmCount
Computer Tablet Group
A computer tablet application to set goals,self-monitor healthy behaviors, record condition-related symptom impact, and self-manage a problematic symptom. Computer Tablet Group: Participants will first meet once with a trained health education specialist. During this meeting the health education specialist will work with the participant in setting constructive and manageable goals and how to achieve them safely. Participants will then receive weekly follow-up phone calls to discuss progression and/or possible trouble-shooting strategies. Participants will be asked to set goals related to increasing self managing health behaviors. Participants will be encouraged to self-monitor goals, behaviors and symptoms using a computer tablet.
15
Paper and Pencil Group
Use of paper and pencil diaries and worksheets to set goals, record condition-related symptom impact, and self-monitor behaviors. Paper and Pencil Group: Participants will first meet once with a trained health education specialist. During this meeting the health education specialist will work with the participant in setting constructive and manageable goals and how to achieve them safely. Participants will then receive weekly follow-up phone calls to discuss progression and/or possible trouble-shooting strategies. Participants will be asked to set goals related to increasing self managing health behaviors. Participants will be encouraged to self-monitor goals, behaviors and symptoms using a paper-pencil diary.
16
Standard Treatment Control Group
Participants are prescribed an exercise program and given information on healthy eating. Standard Treatment Control Group: Participants will first meet once with a health education specialist. During this meeting the health education specialist will provide general information about engaging in healthy behaviors. Information will primarily focus on the benefits of engaging in healthy behaviors and safety precautions. Participants will then receive weekly follow-up phone calls to discuss various health topics.
15
Total46

Baseline characteristics

CharacteristicPaper and Pencil GroupStandard Treatment Control GroupComputer Tablet GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants4 Participants1 Participants10 Participants
Age, Categorical
Between 18 and 65 years
11 Participants11 Participants14 Participants36 Participants
Age, Continuous59.38 years
STANDARD_DEVIATION 10.2
55 years
STANDARD_DEVIATION 11.58
58.93 years
STANDARD_DEVIATION 5.52
57.8 years
STANDARD_DEVIATION 9.48
Region of Enrollment
United States
16 participants15 participants15 participants46 participants
Sex: Female, Male
Female
14 Participants12 Participants13 Participants39 Participants
Sex: Female, Male
Male
2 Participants3 Participants2 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 150 / 160 / 15
serious
Total, serious adverse events
3 / 153 / 161 / 15

Outcome results

Primary

Changes From Baseline in Physical Activity

Physical Activity and Disability Survey-Revised was administered to assess physical activity behavior. Scores can range from -2.7493 to 3.3671. Higher scores on the Physical Activity and Disability Survey-Revised indicates increased physical activity levels.

Time frame: Outcomes were administered immediately before the intervention and again 6-weeks later

ArmMeasureGroupValue (MEAN)Dispersion
Computer Tablet GroupChanges From Baseline in Physical ActivityPretest0.36 units on a scaleStandard Deviation 0.77
Computer Tablet GroupChanges From Baseline in Physical ActivityPosttest0.76 units on a scaleStandard Deviation 0.92
Paper and Pencil GroupChanges From Baseline in Physical ActivityPretest0.31 units on a scaleStandard Deviation 1.01
Paper and Pencil GroupChanges From Baseline in Physical ActivityPosttest0.55 units on a scaleStandard Deviation 1.15
Contact Control GroupChanges From Baseline in Physical ActivityPretest0.43 units on a scaleStandard Deviation 0.68
Contact Control GroupChanges From Baseline in Physical ActivityPosttest0.36 units on a scaleStandard Deviation 0.61
Secondary

Changes From Baseline in 6-minute Walking Test

Time frame: Outcomes were administered immediately before the intervention and again 6-weeks later

ArmMeasureGroupValue (MEAN)Dispersion
Computer Tablet GroupChanges From Baseline in 6-minute Walking TestPretest303.69 metersStandard Deviation 87.23
Computer Tablet GroupChanges From Baseline in 6-minute Walking TestPosttest327.46 metersStandard Deviation 68.32
Paper and Pencil GroupChanges From Baseline in 6-minute Walking TestPretest316.32 metersStandard Deviation 117.58
Paper and Pencil GroupChanges From Baseline in 6-minute Walking TestPosttest320.61 metersStandard Deviation 122.02
Contact Control GroupChanges From Baseline in 6-minute Walking TestPretest362.32 metersStandard Deviation 91.01
Contact Control GroupChanges From Baseline in 6-minute Walking TestPosttest385.23 metersStandard Deviation 82.26
Secondary

Changes From Baseline in Self-Efficacy

Exercise Confidence Survey was used to measure self-efficacy. The survey asks about confidence in sticking to an exercise program and making time for exercise. This is a 12 item questionnaire and scores ranges from 1 to 60. A higher score indicates increased confidence to engage in exercise.

Time frame: Outcomes were administered immediately before the intervention and again 6-weeks later

ArmMeasureGroupValue (MEAN)Dispersion
Computer Tablet GroupChanges From Baseline in Self-EfficacyPretest3.26 units on a scaleStandard Deviation 0.96
Computer Tablet GroupChanges From Baseline in Self-EfficacyPosttest3.25 units on a scaleStandard Deviation 0.82
Paper and Pencil GroupChanges From Baseline in Self-EfficacyPretest3.29 units on a scaleStandard Deviation 0.91
Paper and Pencil GroupChanges From Baseline in Self-EfficacyPosttest3.42 units on a scaleStandard Deviation 0.76
Contact Control GroupChanges From Baseline in Self-EfficacyPretest3.33 units on a scaleStandard Deviation 0.45
Contact Control GroupChanges From Baseline in Self-EfficacyPosttest2.97 units on a scaleStandard Deviation 0.55
Secondary

Changes From Baseline in Self-Report Physical Function

Patient Reported Outcome Measurement information System (PROMIS) Physical Function (PF) was used to measure self-report physical function. Measures are scored on a T-score metric. High scores indicate more of the concept being measured. A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.

Time frame: Outcomes were administered immediately before the intervention and again 6-weeks later

ArmMeasureGroupValue (MEAN)Dispersion
Computer Tablet GroupChanges From Baseline in Self-Report Physical FunctionPretest39.87 units on a scaleStandard Deviation 5.87
Computer Tablet GroupChanges From Baseline in Self-Report Physical FunctionPosttest38.44 units on a scaleStandard Deviation 7.54
Paper and Pencil GroupChanges From Baseline in Self-Report Physical FunctionPretest38.89 units on a scaleStandard Deviation 3.14
Paper and Pencil GroupChanges From Baseline in Self-Report Physical FunctionPosttest37.91 units on a scaleStandard Deviation 4.52
Contact Control GroupChanges From Baseline in Self-Report Physical FunctionPretest42.44 units on a scaleStandard Deviation 5.45
Contact Control GroupChanges From Baseline in Self-Report Physical FunctionPosttest41.51 units on a scaleStandard Deviation 3.96
Secondary

Changes From Baseline in Weight

Time frame: Outcomes were administered immediately before the intervention and again 6-weeks later

Population: 3 participants (2 in the computer tablet group and 1 in the paper and pencil group) were missing weight data for posttest timepoint. These participants were removed from analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Computer Tablet GroupChanges From Baseline in WeightPosttest91.32 kgStandard Deviation 27.97
Computer Tablet GroupChanges From Baseline in WeightPretest91.78 kgStandard Deviation 28.5
Paper and Pencil GroupChanges From Baseline in WeightPretest88.80 kgStandard Deviation 22.12
Paper and Pencil GroupChanges From Baseline in WeightPosttest87.58 kgStandard Deviation 20.12
Contact Control GroupChanges From Baseline in WeightPretest81.71 kgStandard Deviation 22.64
Contact Control GroupChanges From Baseline in WeightPosttest81.56 kgStandard Deviation 23.05

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026